upstreambio.comHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $800MM
Upstream Bio, founded in 2021, is a biotechnology company with the goal of advancing the medical field through genetic technologies and computational methods. Their work predominantly revolves around aiming to develop novel therapeutics for challenging diseases, pushing boundaries in personalized medicine and genomics, and striving for breakthroughs that could significantly enhance human health and lifespan.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/08/2023 | Series B | $200MM | $xx.xx | $676.16MM | Access Biotechnology, Altshuler Shaham Provident Funds Ltd, Bain Capital Life Sciences, Decheng Capital, Enavate Sciences, Hbm Healthcare Investments, Omega Funds, Orbimed, Samsara Biocapital, Tcg X, Venrock Healthcare Capital Partners, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
11,764,693
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Access Biotechnology, Altshuler Shaham Provident Funds Ltd, Bain Capital Life Sciences, Decheng Capital, Enavate Sciences, Hbm Healthcare Investments, Omega Funds, Orbimed, Samsara Biocapital, Tcg X, Venrock Healthcare Capital Partners, Wellington Management
|
||||||
06/02/2022 | Series A | $200MM | $xx.xx | $272MM | Access Biotechnology, Altshuler Shaham Provident Funds, Decheng Capital, Hbm Healthcare Investments, Maruho Company, Omega Funds, Orbimed, Samsara Biocapital, Tcg X | |
Price per Share
$xx.xx
Shares Outstanding
20,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Access Biotechnology, Altshuler Shaham Provident Funds, Decheng Capital, Hbm Healthcare Investments, Maruho Company, Omega Funds, Orbimed, Samsara Biocapital, Tcg X
|